Eur Heart J

1. FATIMA M, Sheikh S, Ammer Z
   Bridging The Gaps In EMPEROR-Preserved: Toward safer and smarter use of Empagliflozin in resistant hypertension and heart failure with preserved ejection fraction.
   Eur Heart J. 2025 Nov 4:ehaf799. doi: 10.1093.
   

   >> Share

   
   
2. TOKCAN M, Markwirth P, Bohm M
   Uniform benefits of empagliflozin across hypertension categories: a response.
   Eur Heart J. 2025 Nov 4:ehaf798. doi: 10.1093.
   

   >> Share

   
   

   
   Eur J Pharmacol

3. BAI Y, Jiang Y, Zhou Y, Xia Y, et al
   The Role of Ferroptosis in the Pathogenesis of Pulmonary Hypertension and Its Therapeutic Potential.
   Eur J Pharmacol. 2025 Nov 1:178316. doi: 10.1016/j.ejphar.2025.178316.
   

   >> Share

   
   

   
   Hypertension

4. MAISONS V, Demir F, Fillon A, Delalande P, et al
   Renal Histology Findings in Malignant Hypertension, a Systematic Review.
   Hypertension. 2025 Nov 4. doi: 10.1161/HYPERTENSIONAHA.125.25069.
   

   >> Share

   
   
5. CHOI H, Panja S, Nguyen HN, Stark RJ, et al
   Smooth Muscle LRRC8A Knockout Preserves Vascular Function in Ang II Hypertension.
   Hypertension. 2025 Nov 4. doi: 10.1161/HYPERTENSIONAHA.125.25222.
   

   >> Share

   
   
6. KARIO K, Tomitani N, Harada N, Morimoto T, et al
   Efficacy Determinants of Hypertension Digital Therapeutics: The B-INDEX Study.
   Hypertension. 2025 Nov 3. doi: 10.1161/HYPERTENSIONAHA.125.25028.
   

   >> Share

   
   
7. ZAND J, Miao J, Hommos MS, Schwartz GL, et al
   Performance of Large Language Models in Analyzing Common Hypertension Scenarios.
   Hypertension. 2025 Nov 3. doi: 10.1161/HYPERTENSIONAHA.125.25492.
   

   >> Share

   
   

   
   J Cardiovasc Pharmacol

8. BIONDI-ZOCCAI G, Abbate A, Booz GW
   Baxdrostat: the new kid on the block for the treatment of resistant hypertension.
   J Cardiovasc Pharmacol. 2025 Nov 5. doi: 10.1097/FJC.0000000000001771.
   

   >> Share

   
   

   
   J Hum Hypertens

9. ANGEL-KORMAN A, Mayer O, Brosh-Nissimov T, Leiba A, et al
   Infection with COVID-19 does not increase blood pressure in patients with chronic kidney disease.
   J Hum Hypertens. 2025;39:777-783.
   

   >> Share

   
   
10. ARGYRIS AA, Baker D, Charnley P, Howe L, et al
    Effect of digital messaging on blood pressure control in general practice: observations from the BP@Home programme in wirral area.
    J Hum Hypertens. 2025;39:770-776.
    

    >> Share

    
    
11. PARIS NS, Okawa RTP, Lopes WA
    The need to distinguish office and ambulatory blood pressure in evaluating Pilates efficacy in hypertension.
    J Hum Hypertens. 2025 Nov 1. doi: 10.1038/s41371-025-01091.
    

    >> Share

    
    

    
    J Hypertens

12. MANDAL AK, Rana T, Shrestha S, Mat Hassan MK, et al
    Effectiveness of aerobic exercise in reducing blood pressure among obese adults: systematic review and meta-analysis.
    J Hypertens. 2025;43:1923-1936.
    

    >> Share

    
    
13. BEZERRA R, Feitosa ADM, Guimaraes-Neto VS, Barbosa R, et al
    Achieving blood pressure control with monotherapy: real-world evidence from office and home blood pressure measurements.
    J Hypertens. 2025;43:2075-2078.
    

    >> Share

    
    
14. ROCHE-GOMEZ A, Blazquez Gomez CJ, Licero Villanueva A, Espino Hernandez M, et al
    Novel homozygous pathogenic variant in HSD11B2 as a cause of apparent mineralocorticoid excess.
    J Hypertens. 2025;43:2072-2074.
    

    >> Share

    
    
15. ZHANG Y, Tian P, Zeng F, Huang B, et al
    Computed tomography-guided ozone neurolysis lowers blood pressure.
    J Hypertens. 2025;43:2079-2085.
    

    >> Share

    
    
16. PASDAR Z, Chandanani M, Dhillon N, Carter B, et al
    Hypertensive disorders of pregnancy increase the risk of future ophthalmic disorders: a systematic review and meta-analysis.
    J Hypertens. 2025;43:1903-1911.
    

    >> Share

    
    
17. JIANG Q, Ji G, Huang P, Huang X, et al
    Trend in hypertension prevalence, awareness, treatment, and control rates among adult residents in Guangdong province, southern China, 2002~2022.
    J Hypertens. 2025;43:1953-1962.
    

    >> Share

    
    
18. LIU C, Wang J, Chi J, Dong Y, et al
    Inhibition of calcium-sensitive receptors ameliorates myocardial fibrosis, in Dahl salt-sensitive rats.
    J Hypertens. 2025;43:1972-1983.
    

    >> Share

    
    
19. ANTZA C, Anyfanti P, Kotoulas SC, Kotsis V, et al
    Diagnostic accuracy of blood pressure measurement methods for hypertension screening in obesity: does one fit all?
    J Hypertens. 2025;43:1991-1998.
    

    >> Share

    
    
20. CAI A, Cheng Q, Zhou D, Feng X, et al
    Risk reclassification and cost-effectiveness of echocardiography for cardiovascular primary prevention in hypertension in China.
    J Hypertens. 2025;43:1999-2007.
    

    >> Share

    
    
21. ROSTAMIAN S, Kaura A, Ariti C, Gupta A, et al
    The impact of blood pressure variability on cardiovascular and renal outcomes in patients with and without diabetes: insights from the Anglo-Scandinavian Cardiac Outcomes Trial.
    J Hypertens. 2025;43:2033-2041.
    

    >> Share

    
    
22. DENG B, Liu W
    Advancing understanding of racial disparities in hypertension: does Factor IX illuminate or confound?
    J Hypertens. 2025;43:2086-2087.
    

    >> Share

    
    
23. PANG G, Wang L
    From cost savings to clinical benefits: thoughts on economic evaluation of single pill combinations in hypertension.
    J Hypertens. 2025;43:2088-2089.
    

    >> Share

    
    
24. STOUTENBURG EG, Long DL, Plante TB
    Considerations on conducting observational research of thromboinflammation and incident hypertension.
    J Hypertens. 2025;43:2090.
    

    >> Share

    
    
25. ATKINS ER, Pikkemaat M, Rodgers A, Schutte AE, et al
    Reply to comment: Treating hypertension with single pill combinations: a simple strategy to save costs for the patients and payers.
    J Hypertens. 2025;43:2091.
    

    >> Share

    
    
26. MEMON ME, Aun SM
    Letter to the editor: limitations in assessing long term risks after hypertensive emergencies.
    J Hypertens. 2025;43:2092.
    

    >> Share

    
    
27. BUCCI T, Lip GYH
    Reply: risk estimation following hypertensive crises.
    J Hypertens. 2025;43:2094.
    

    >> Share

    
    
28. SCHLAICH MP, Weber MA, Flack JM, Danaietash P, et al
    Effects of aprocitentan on prognostically relevant ambulatory blood pressure-derived variables in resistant hypertension.
    J Hypertens. 2025 Oct 2. doi: 10.1097/HJH.0000000000004174.
    

    >> Share

    
    

    
    PLoS One

29. MEDDAR JM, Mann D, Schwartz M, Park HG, et al
    Associations between remote patient monitoring and uncontrolled blood pressure among patients diagnosed with hypertension: Exploring variations by race/ethnicity.
    PLoS One. 2025;20:e0334887.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share